MAZE logo

Maze Therapeutics, Inc. (MAZE) Selling, General & Administrative Expenses

Annual SG&A:

$26.42M+$1.81M(+7.36%)
December 31, 2024

Summary

  • As of today, MAZE annual SG&A is $26.42 million, with the most recent change of +$1.81 million (+7.36%) on December 31, 2024.
  • During the last 3 years, MAZE annual SG&A has risen by +$3.58 million (+15.70%).
  • MAZE annual SG&A is now at all-time high.

Performance

MAZE SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

Quarterly SG&A:

$7.78M-$591.00K(-7.06%)
September 30, 2025

Summary

  • As of today, MAZE quarterly SG&A is $7.78 million, with the most recent change of -$591.00 thousand (-7.06%) on September 30, 2025.
  • Over the past year, MAZE quarterly SG&A has increased by +$903.00 thousand (+13.14%).
  • MAZE quarterly SG&A is now -7.06% below its all-time high of $8.37 million, reached on June 30, 2025.

Performance

MAZE Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

TTM SG&A:

-$1.63B-$141.10M(-9.48%)
September 30, 2025

Summary

  • As of today, MAZE TTM SG&A is -$1.63 billion, with the most recent change of -$141.10 million (-9.48%) on September 30, 2025.
  • Over the past year, MAZE TTM SG&A has dropped by -$1.64 billion (-23812.33%).
  • MAZE TTM SG&A is now -311.82% below its all-time high of -$395.69 million.

Performance

MAZE TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

MAZE Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+7.4%+13.1%-10000.0%
3Y3 Years+15.7%+100.0%-100.0%
5Y5 Years+15.7%+100.0%-100.0%

MAZE Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+15.7%-7.1%>+9999.0%-311.8%at low
5Y5-Yearat high+15.7%-7.1%>+9999.0%-311.8%at low
All-TimeAll-Timeat high+15.7%-7.1%>+9999.0%-311.8%at low

MAZE Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2025
-
$7.78M(-7.1%)
$31.47M(+3.0%)
Jun 2025
-
$8.37M(+7.0%)
$30.57M(+37.7%)
Mar 2025
-
$7.82M(+4.1%)
$22.20M(+54.4%)
Dec 2024
$26.42M
$7.51M(+9.3%)
$14.38M(+109.3%)
DateAnnualQuarterlyTTM
Sep 2024
-
$6.87M(>+9900.0%)
$6.87M(>+9900.0%)
Mar 2024
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2023
$24.61M(+7.8%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2023
-
$0.00
$0.00
Dec 2022
$22.83M
-
-

FAQ

  • What is Maze Therapeutics, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. annual SG&A year-on-year change?
  • What is Maze Therapeutics, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. quarterly SG&A year-on-year change?
  • What is Maze Therapeutics, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. TTM SG&A year-on-year change?

What is Maze Therapeutics, Inc. annual SG&A?

The current annual SG&A of MAZE is $26.42M

What is the all-time high annual SG&A for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high annual SG&A is $26.42M

What is Maze Therapeutics, Inc. annual SG&A year-on-year change?

Over the past year, MAZE annual SG&A has changed by +$1.81M (+7.36%)

What is Maze Therapeutics, Inc. quarterly SG&A?

The current quarterly SG&A of MAZE is $7.78M

What is the all-time high quarterly SG&A for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high quarterly SG&A is $8.37M

What is Maze Therapeutics, Inc. quarterly SG&A year-on-year change?

Over the past year, MAZE quarterly SG&A has changed by +$903.00K (+13.14%)

What is Maze Therapeutics, Inc. TTM SG&A?

The current TTM SG&A of MAZE is -$1.63B

What is the all-time high TTM SG&A for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high TTM SG&A is -$395.69M

What is Maze Therapeutics, Inc. TTM SG&A year-on-year change?

Over the past year, MAZE TTM SG&A has changed by -$1.64B (-23812.33%)
On this page